SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
marinzou
Lv4
570 积分
2023-04-25 加入
最近求助
最近应助
互助留言
The antibody–drug conjugate landscape
2天前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
3天前
已完结
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
3天前
已完结
Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
6天前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
8天前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
8天前
已完结
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
8天前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
8天前
已完结
Targeting KRAS in cancer
10天前
已完结
Teclistamab in Relapsed or Refractory Multiple Myeloma
1个月前
已完结
没有进行任何应助
感谢,速度真快,帮大忙了
2天前
点赞,速度真快,帮大忙了
3天前
感谢,帮大忙了,么么哒
3天前
感谢,速度真快,点赞
8天前
帮大忙了,速度真快,点赞
8天前
帮大忙了,么么哒,速度真快
8天前
速度真快,速度真快,帮大忙了,么么哒
1个月前
点赞,速度真快,帮大忙了
1个月前
帮大忙了,速度真快,点赞
1个月前
点赞,么么哒,帮大忙了
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论